BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 30388851)

  • 1. Is It Time to Use Probiotics to Prevent or Treat Obesity?
    Brusaferro A; Cozzali R; Orabona C; Biscarini A; Farinelli E; Cavalli E; Grohmann U; Principi N; Esposito S
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30388851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity.
    Sergeev IN; Aljutaily T; Walton G; Huarte E
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the microbiota and probiotics in obesity.
    Fontané L; Benaiges D; Goday A; Llauradó G; Pedro-Botet J
    Clin Investig Arterioscler; 2018; 30(6):271-279. PubMed ID: 29804899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic Strains and Intervention Total Doses for Modulating Obesity-Related Microbiota Dysbiosis: A Systematic Review and Meta-analysis.
    López-Moreno A; Suárez A; Avanzi C; Monteoliva-Sánchez M; Aguilera M
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32610476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota is associated with adiposity markers and probiotics may impact specific genera.
    Gomes AC; Hoffmann C; Mota JF
    Eur J Nutr; 2020 Jun; 59(4):1751-1762. PubMed ID: 31250099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults.
    Hibberd AA; Yde CC; Ziegler ML; Honoré AH; Saarinen MT; Lahtinen S; Stahl B; Jensen HM; Stenman LK
    Benef Microbes; 2019 Mar; 10(2):121-135. PubMed ID: 30525950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut enterotypes are stable during Bifidobacterium and Lactobacillus probiotic supplementation.
    Haddad EN; Sugino KY; Tucker RM; Comstock SS
    J Food Sci; 2020 May; 85(5):1596-1604. PubMed ID: 32267970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
    Rutten NB; Gorissen DM; Eck A; Niers LE; Vlieger AM; Besseling-van der Vaart I; Budding AE; Savelkoul PH; van der Ent CK; Rijkers GT
    PLoS One; 2015; 10(9):e0137681. PubMed ID: 26378926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Probiotics on the Microbiota: Effect on Obesity.
    Nova E; Pérez de Heredia F; Gómez-Martínez S; Marcos A
    Nutr Clin Pract; 2016 Jun; 31(3):387-400. PubMed ID: 26869611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and probiotics: Focus on diabetes mellitus.
    Bordalo Tonucci L; Dos Santos KM; De Luces Fortes Ferreira CL; Ribeiro SM; De Oliveira LL; Martino HS
    Crit Rev Food Sci Nutr; 2017 Jul; 57(11):2296-2309. PubMed ID: 26499995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of probiotic treatment in obesity: a review.
    Mekkes MC; Weenen TC; Brummer RJ; Claassen E
    Benef Microbes; 2014 Mar; 5(1):19-28. PubMed ID: 23886977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans - towards treatment with probiotics.
    Stenman LK; Burcelin R; Lahtinen S
    Benef Microbes; 2016 Feb; 7(1):11-22. PubMed ID: 26565087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of probiotics therapy to obesity: a therapy that has gained considerable momentum.
    Kang Y; Cai Y
    Hormones (Athens); 2018 Jun; 17(2):141-151. PubMed ID: 29858841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials.
    Crovesy L; Ostrowski M; Ferreira DMTP; Rosado EL; Soares-Mota M
    Int J Obes (Lond); 2017 Nov; 41(11):1607-1614. PubMed ID: 28792488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut bacterial microbiota and obesity.
    Million M; Lagier JC; Yahav D; Paul M
    Clin Microbiol Infect; 2013 Apr; 19(4):305-13. PubMed ID: 23452229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Obesity: A Role for Probiotics.
    Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.